Literature DB >> 9195079

Invasive mold sinusitis: 17 cases in immunocompromised patients and review of the literature.

P C Iwen1, M E Rupp, S H Hinrichs.   

Abstract

A 10-year retrospective analysis of invasive mold infections in hospitalized patients was performed to characterize the epidemiology and clinical features of invasive fungal sinusitis. Seventeen cases of invasive mold sinusitis were identified. Eleven cases were caused by Aspergillus flavus, three were caused by unspecified species, and one each was caused by Aspergillus fumigatus, Rhizopus species, and Alternaria species, respectively. Fifteen patients had hematologic malignancies, and two had end-stage liver disease. The most common presenting symptom was periorbital swelling (seven patients). Sinusitis was diagnosed a median of 19 days after admission. Eight patients (47%) survived; six of these patients were treated with both amphotericin B and surgery. Postmortem examination of six patients showed evidence of disseminated disease; the brain was the most common extrapulmonary site (four patients). To our knowledge, this is the largest currently reported series on invasive mold sinusitis; our report extends the information on invasive mold sinusitis and shows that aggressive therapeutic and surgical interventions are needed to prevent rapid progression of disease in immunocompromised patients.

Entities:  

Mesh:

Year:  1997        PMID: 9195079     DOI: 10.1086/513662

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  26 in total

1.  Effect of immunosuppression on the clinicopathological changes in experimental zygomycosis in rabbits.

Authors:  J Sondhi; P P Gupta
Journal:  Vet Res Commun       Date:  2000-05       Impact factor: 2.459

2.  Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards.

Authors:  A Espinel-Ingroff; M Bartlett; V Chaturvedi; M Ghannoum; K C Hazen; M A Pfaller; M Rinaldi; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Sinusitis in the Immunocompromised Host.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

4.  [Classification of etiologic agents in fungal sinusitis by immunohistochemistry, histology and culture].

Authors:  K Wölke; G Jautzke; O Kaschke; B Seefeld
Journal:  Pathologe       Date:  2004-09       Impact factor: 1.011

5.  Evaluation of disk diffusion and Etest compared to broth microdilution for antifungal susceptibility testing of posaconazole against clinical isolates of filamentous fungi.

Authors:  Shawn A Messer; Daniel J Diekema; Richard J Hollis; Linda B Boyken; Shailesh Tendolkar; Jennifer Kroeger; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2007-01-31       Impact factor: 5.948

6.  Acute invasive fungal rhinosinusitis: our experience with 19 patients.

Authors:  Ahmet Emre Süslü; Oğuz Oğretmenoğlu; Nilda Süslü; Omer TaşkIn Yücel; Tevfik Metin Onerci
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-05-10       Impact factor: 2.503

7.  E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method.

Authors:  Ana Espinel-Ingroff; A Rezusta
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

8.  Deadly Sphenoid Fungus-Isolated Sphenoid Invasive Fungal Rhinosinusitis: A Case Report.

Authors:  Jason E Gilde; Christopher C Xiao; Victoria A Epstein; Jonathan Liang
Journal:  Perm J       Date:  2017

9.  Invasive fungal sinusitis caused by Scytalidium dimidiatum in a lung transplant recipient.

Authors:  James J Dunn; Michael J Wolfe; Joel Trachtenberg; John D Kriesel; Richard R Orlandi; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

10.  In vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp.

Authors:  Alicia Gomez-Lopez; Guillermo Garcia-Effron; Emilia Mellado; Araceli Monzon; Juan L Rodriguez-Tudela; Manuel Cuenca-Estrella
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.